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Abstract
Bacterial conjugation in the human gut microbiota is believed to play a major role in the dissemination of antibiotic
resistance genes and virulence plasmids. However, the modulation of bacterial conjugation by the human host remains
poorly understood and there is a need for controlled systems to study this process. We established an in vitro co-culture
system to study the interaction between human intestinal cells and bacteria. We show that the conjugation efficiency of a
plasmid encoding an extended spectrum beta-lactamase is reduced when clinical isolates of Escherichia coli are co-cultured
with human intestinal cells. We show that filtered media from co-cultures contain a factor that reduces conjugation
efficiency. Protease treatment of the filtered media eliminates this inhibition of conjugation. This data suggests that a
peptide or protein based factor is secreted on the apical side of the intestinal cells exposed to bacteria leading to a two-fold
reduction in conjugation efficiency. These results show that human gut epithelial cells can modulate bacterial conjugation
and may have relevance to gene exchange in the gut.
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Introduction
The human body is inhabited by a vast number of microor-
ganisms collectively referred to as the microbiota [1–3]. The
microbiota colonizes every surface of the human body exposed to
the environment, including skin, genitourinary, respiratory, and
gastrointestinal tracts [3–5], with the gastrointestinal tract as the
most heavily colonized site in the body [6,7]. The relationship
between the host and its resident microbiota can be mutually
beneficial and the microbiota has substantial impact on human
health, including dietary and nutritional processing, prevention of
pathogen invasion and immune system maturation [8–10].
Communication between the human host and its microbiota is
necessary for many of these processes. The intestine provides an
extensive platform for intercellular signaling between the micro-
biota, the host, and incoming pathogens. Indeed, intestinal
microorganisms secrete molecules that can be sensed by their
host, and can also sense host-produced molecules [11,12]. In
addition to such host-microbiota metabolic and signaling interac-
tions, microorganisms also exchange genetic material between
them in the gastrointestinal tract. This process of horizontal gene
transfer has been implicated in clinical problems with antibiotic
resistance [13,14]. In fact, exchange of antibiotic resistance genes
between resistant and susceptible bacteria have been studied in
animals and humans [15–17].
Horizontal gene transfer can occur through transformation,
transduction, and conjugation. It is currently believed that
conjugation is the major contributor to the dissemination of
antibiotic resistance genes [18]. Conjugation involves the transfer
of DNA between cells in a contact-dependent fashion. Plasmids,
conjugative transposons, regions of bacterial chromosomes, and
integrative and conjugative elements can be transferred via
conjugation between remotely related organisms [19–23]. While
conjugation is recognized to play a key role in the dissemination of
antibiotic resistance genes, the influence of the human host on
conjugational transfer remains controversial. Several studies have
reported inefficient enterobacterial conjugation in intestinal
extracts from mice [24] and in the mammalian gut [25,26]. Yet,
other reports identified higher rates of conjugation in the gut
[27,28]. Several factors, including pathogen-driven inflammatory
responses occurring in the gut could explain some of these
disagreements [29–34]. However, there is a need to establish well-
controlled model systems in order to improve our understanding of
the specific host derived factors that affect bacterial conjugation
[35]. In this study we establish such an in vitro experimental system
using intestinal epithelial cells in co-culture with clinical E. coli
isolates able to donate and receive an ESBL (extended spectrum
beta-lactamase) plasmid. We used this system to determine the
impact of human intestinal cells on bacterial conjugation and
discovered that an unknown protein or peptide based factor is
secreted by intestinal cells reducing the efficiency of bacterial
conjugation.
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Materials and Methods
Cell culture, E. coli strains, and growth conditions
Human Caco-2 colorectal adenocarcinoma cells (ECACC
86010202) were grown in transwell filters (Corning) and main-
tained in Minimal Essential Media (MEM) (Life Technologies)
supplemented with 20% fetal bovine serum, 25 mg/mL gentamy-
cin (Sigma), and 0.1 mM non-essential amino acids (Sigma) for 21
days until differentiation occurred. The cell line was maintained at
37uC under 5% CO2 humidified atmosphere.
Co-culture was performed using E. coli clinical isolates Ec77 and
Ec56 (kind gift from Dr. Kristian Schønning, Hvidovre Hospital).
Ec77 has an ESBL plasmid and is considered the donor strain.
The recipient strain, Ec56, has a kanamycin resistance gene and a
gene encoding red fluorescent protein inserted in its Tn7 site.
Ec77 and Ec56 were grown in LB supplemented with cefotaxime
2 mg/ml or kanamycin 40 mg/ml, respectively.
Co-culture of Human Cells
After 21 days of culture, Caco-2 cells were washed three times
with phosphate-buffered saline (PBS) 16 and incubated in
antibiotic-free medium overnight. E. coli colonies were grown
overnight and added to the apical side of the intestinal cells at a
multiplicity of infection (MOI) of 10 bacteria per cell. Cultures
were maintained at 37uC under a 5% CO2 humidified
atmosphere. Control samples were processed similarly in the
absence of intestinal cells. After 2 hours of infection, the media
from the apical side of the Caco-2 cells was recovered and plated
at the appropriate dilutions in LB plates with cefotaxime 2 mg/ml,
kanamycin 40 mg/ml and cefotaxime 2 mg/ml plus kanamycin
40 mg/ml.
Protease Treatment
Using Caco-2 cells, co-culture was performed as previously
described. Media from the apical side was collected, filtered and
treated with 2 mg/ml protease (unspecific protease from Strepto-
myces griseus; Sigma) for 10 minutes at room temperature.
Treatment with 1:100 protease inhibitor cocktail (inhibits serine,
cysteine, aspartic proteases and aminopeptidases; Sigma) at room
temperature followed. E. coli strains Ec56 and Ec77 were then
cultured in the protease treated media for 2 hours. Control
samples were processed similarly in the absence of protease
treatment.
Analysis of Conjugation Efficiency
Conjugation efficiency was calculated in the following manner:
number of transconjugants divided by the total number of donor
bacteria. Number of transconjugants was calculated by counting
the colonies in LB plates with cefotaxime 2 mg/ml plus kanamycin
40 mg/ml. Total number of donor bacteria was calculated by
counting the colonies in LB plates with cefotaxime 2 mg/ml.
Statistical analysis
Conjugation efficiency results were expressed as mean 6 SEM
of at least three independent experiments and analyzed by
Figure 1. Bacterial conjugation efficiency after co-culture with intestinal cells. (A) Experimental setting. Overview of the setting in a
transwell filter and zoom from an area of the filter. In orange and blue are depicted the donor and recipient E. coli strains when co-cultured with the
intestinal cells without prior treatment. Transconjugants are in green. (B) Efficiency of conjugation after 2 hours of culture of donor and recipient E.
coli in the presence or absence (w/o) of differentiated intestinal cells, Caco-2. Means 6 SEM. Representative of five (with Caco-2 cells) and three
(without Caco-2 cells) independent experiments. *, statistically significant from culture with Caco-2 cells (Student’s t test; p=0.023).
doi:10.1371/journal.pone.0100739.g001
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Student’s t test. The differences between data sets were considered
significant at P values ,0.05.
Results
Bacterial conjugation efficiency is lower in the presence
of intestinal epithelial cells
In order to study the potential influence of human intestinal
cells on the ability of bacteria to transfer genetic material between
them, we used two E. coli clinical isolates. The donor strain harbors
an ESBL plasmid and the recipient strain has a kanamycin
resistance gene and a gene encoding red fluorescent protein
inserted in its Tn7 site. The strains were cultured for 2 hours in the
presence or absence of differentiated intestinal epithelial cells
(Fig. 1A). The intestinal epithelial cells were not exposed to any
prior treatment before co-culture with E. coli. After this period of
co-culture it was observed that conjugation efficiency of bacteria
cultured in the presence of the intestinal epithelial cells
(4.5161025) presented a two-fold decrease compared to when
cultured in the absence of intestinal cells (8.461025; p = 0.023)
(Fig. 1B). These results show that the presence of intestinal cells
decreases the ability of these bacterial strains to perform plasmid
conjugation. We recovered a similar number of donor, recipient
and transconjugant bacteria after 2 hours in the presence or
absence of intestinal cells (Table S1). This observation indicated
that the decrease in bacterial conjugation was not due to bacterial
killing induced by the intestinal cells.
To test whether the reduced conjugation efficiency was
dependent on direct contact with the differentiated epithelial cells,
we co-cultured E. coli donor and recipient strains for 2 hours in the
presence or absence of differentiated intestinal epithelial cells. The
media from the apical side of the intestinal cells, which represent
the intestinal lumen, was recovered and filtered. Fresh donor and
recipient strains were co-cultured for 2 hours in the filtered media
and the conjugation efficiency was quantified (Fig. 2A). In this set
of experiments we also observed a significantly lower conjugation
efficiency in the media that had previously been in contact with
intestinal cells (3.4561025) compared to the media that had not
been in contact with the intestinal cells (5.8961025; p = 0.013)
(Fig. 2B). The efficiency of conjugation in the media that had been
in contact with pre-infected intestinal cells was also significantly
lower compared to the efficiency of conjugation in the media that
had been in contact with intestinal cells where no pre-infection
occurred (6.0861025; p = 0.0065) (Fig. 2B). In view of these results
we suggest that upon culture with bacteria, intestinal cells secrete
an unknown factor that decreases the ability of bacterial cells to
perform conjugation.
Similar experiments were performed with the media from the
basal side of the intestinal cells. However, no effect was observed
on the conjugation efficiency of the bacterial strains (Fig. S1).
Therefore we suggest that the unknown factor secreted by the
intestinal cells that has an influence on the conjugation efficiency is
secreted by the apical side of the intestinal cells.
Figure 2. Bacterial conjugation efficiency after culture with media from pre-infected intestinal cells. (A) Experimental setting. In orange
and blue are depicted the donor and recipient E. coli strains when co-cultured with the intestinal cells and in the filtered media. Transconjugants are
in green. (B) Efficiency of conjugation after 2 hours of culture of donor and recipient E. coli in culture media that had previously been cultured with or
without E. coli in the presence or absence (w/o) of differentiated intestinal cells, Caco-2. Means6 SEM. Representative of three (with Caco-2 cells), five
(without Caco-2 cells) and four (with Caco-2 cells and without initial pre-infection with E. coli) independent experiments. *, statistically significant
from culture with pre-infected Caco-2 cells (Student’s t test; p= 0.013, for without Caco-2 cells; p=0.0065, for with Caco-2 cells without pre-infection).
doi:10.1371/journal.pone.0100739.g002
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Bacterial conjugation is impaired by an unknown peptide
or protein secreted by intestinal cells
We wanted to determine if the unknown factor reducing
conjugation efficiency, secreted by the intestinal cells when in
culture with bacteria, was a protein or peptide based factor. To
test this we co-cultured intestinal cells with donor and recipient E.
coli strains for 2 hours. Media from the apical side of the intestinal
cells was recovered, filtered, and treated with an unspecific
protease from Streptomyces griseus. After treatment, donor and
recipient E. coli strains were cultured in the media for 2 hours
(Fig. 3A). It was observed that in the media that had been treated
with protease there was a significantly higher conjugation
efficiency (7.4861025) compared to the media that had not been
subjected to the treatment (4.8361025; p = 0.0084) (Fig. 3B).
Therefore we suggest that the unknown factor secreted by the
intestinal cells which induces lower conjugation efficiency is a
peptide or protein, as protease treatment inhibits the effect of the
secreted factor.
Discussion
Bacterial conjugation is considered a major contributor to the
dissemination of antibiotic resistance genes in the human gut [18].
Yet, we have a limited understanding of how host factors affect
conjugation. We developed an in vitro model system that enables
controlled investigation of the specific host derived factors that
affect bacterial conjugation.
Using this in vitro co-culture system we observed that the
conjugation efficiency is lowered when clinical E. coli isolates are
co-cultured with intestinal cells. Our results are in agreement with
previous work demonstrating that plasmid transfer between
isogenic strains of E. coli occurs at a much lower rate in intestinal
extracts from mice than in laboratory media [24]. Several other
studies report inefficient enterobacterial conjugation in the
mammalian gut [25,26]. Yet, other studies identified higher rates
of conjugation in the gut [27,28], suggesting that poorly
understood in vivo factors affect transfer of genetic material [29].
For instance, pathogen-driven inflammatory responses occurring
in the gut, mediated by the immune system, have been shown to
increase in vivo conjugation rates, due to a boost in enterobacterial
colonization [29–34].
In our study, after observing that intestinal cells influence
bacterial conjugation efficiency we showed that physical contact
between intestinal cells and bacteria is not required for the
conjugation process per se. Instead it is suggested that an unknown
factor is secreted on the apical side of the epithelial cells that
decreases bacterial conjugation. Similar examples of such com-
munication and interaction between host and bacteria through
secreted, diffusible molecules have been reported [36–40]. Finally,
we show that protease treatment of the media containing this
factor abolishes its inhibitory effect suggesting that the secreted
factor is an unknown peptide or protein. Future studies are needed
in order to establish the identity of this factor and its relevance in
vivo as well as to determine the interest of this factor as an adjuvant
Figure 3. Bacterial conjugation efficiency after culture with protease-treated media from pre-infected intestinal cells. (A)
Experimental setting. In orange and blue are depicted the donor and recipient E. coli strains when co-cultured with the intestinal cells and in the
filtered media. Transconjugants are in green. (B) Frequency of conjugation after 2 hours of culture of donor and recipient E. coli in culture media that
had previously been cultured with E. coli in the presence of differentiated intestinal cells, Caco-2. In this media a protease treatment was applied
before the second culture of donor and recipient E. coli strains. W/o Protease: without protease treatment. Means 6 SEM. Representative of three
independent experiments. *, statistically significant from protease treatment (Student’s t test; p=0.0084).
doi:10.1371/journal.pone.0100739.g003
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in antibiotic treatment in order to prevent or decrease the number
of antibiotic resistant infections [41].
Supporting Information
Figure S1 Bacterial conjugation efficiency after co-
culture with basal side of intestinal cells. Efficiency of
conjugation after 2 hours of culture of donor and recipient E. coli
in the presence or absence (w/o) of differentiated intestinal cells. E.
coli was co-cultured on the basal side of the intestinal cells. Means
6 SEM. Representative of three independent experiments.
(Student’s t test; p = 0.987).
(TIF)
Table S1 Number of donor and recipient E. coli
colonies recovered after 2 hours of culture in intestinal
cell media. After 2 hours of culture, the media from the apical
side of the Caco-2 cells was recovered and plated at the
appropriate dilutions in LB plates with cefotaxime 2 mg/ml and
kanamycin 40 mg/ml. Numbers correspond to the average
number of colonies obtained after co-culture with intestinal cells
(Fig. 1) and after culture with media from pre-infected intestinal
cells (Fig. 2). p value was calculated using Student’s t test between
the replicates of ‘‘with cells’’ and ‘‘without cells’’ conditions.
(DOCX)
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